Multidrug resistant Gram-negative bacilli in lower respiratory tract infections
,
Abstract
Background: Lower respiratory tract infections are among important causes of morbidity and mortality for all age groups. The emergence of multidrug resistant Gram-negative bacilli is an issue of increasing concern.
Materials and Methods: A retrospective study including respiratory specimens (sputum and BAL) was conducted in our tertiary care centre. Samples were processed for microscopy, culture and susceptibility testing following standard methods. Multidrug resistant Gram-negative bacilli causing lower respiratory tract infections were studied for their causation of disease. The effect of appropriate treatment on clinical outcome was observed.
Results: A total of 472 Gram-negative pathogens were isolated from sputum and broncho-alveolar lavage fluid specimens during the study period. Among these Gram-negative pathogens 175 (37%) were found to be multidrug resistant. Klebsiella pneumoniae 85 (48.6%) and Acinetobacter spp. 59 (33.7%) were the predominant multidrug resistant Gram-negative bacilli isolated. Based on clinico-microbiological correlation, 138 (78.9%) multidrug resistant isolates were found to be pathogenic and the rest 37 (21.1%) were considered as colonizers. After initiating appropriate antibiotic therapy, clinical improvement was seen in 110 (79.7%) patients. In the patients who showed improvement, amikacin (34.3%) and cefoperazone-sulbactum (21.8%) were found to be the most effective drugs.
Conclusion: A large majority of the isolated multidrug resistant Gram-negative bacilli were found to be pathogenic. Regular surveillance which directs appropriate empirical therapy; and good clinic-microbiological workup of each case of lower respiratory tract infection can reduce the morbidity and mortality associated with multidrug resistant organisms.
Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Leven M. Guidelines for the management of adult lower respiratory tract infections - Full version. Clin Microbiol Infect 2011; 17 Suppl 6: E1-59.
Carroll KC. Laboratory Diagnosis of Lower Respiratory Tract Infections: Controversy and Conundrums. J Clin Microbiol 2002; 40: 3115-3120.
Egbe CA, Ndiokwere C, Omoregie R. Microbiology of lower respiratory tract infections in Benin City, Nigeria. Malays J Med Sci 2011; 18: 27-31.
Pop-Vicas AE, D’Agata EMC. The rising influx of multidrug-resistant Gram-negative bacilli into a tertiary care Hospital. Clin Infect Dis 2005; 40: 1792-1798.
Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI. Appraising contemporary strategies to combat multidrug resistant Gram-negative bacterial infections– proceedings and data from the Gram-negative resistance summit. Clin Infect Dis 2011; 53(S2): S33-55.
Lentino JR, Lucks DA. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol 1987; 25: 758-762.
Chastre J, Combes A, Luyt CE. The invasive (Quantitative) diagnosis of ventilator-associated pneumonia. Respir Care 2005; 50: 797-807.
Collee JG, Miles RS, Watt B (1996). Tests for identification of bacteria. In: Mackie and McCartney Practical Medical Microbiology. Ed, Collee JG, Fraser AG, Marmion BP, Simmons A. Churchill Livingstone,14th ed. New York, pp. 131-149.
Clinical and Laboratory Standards Institute (2011). performance standards for antimicrobial susceptibility testing. twenty-first informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute. Wayne, Pennsylvania, USA.
Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR et al. Effects of phenotype and genotype on methods for detection of extended- spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007; 45: 199-205.
Gilbert DN, Guidos RJ, Boucher HW, Talbot GH, Spellberg B, Edwards Jr JE et al. The 10 × ′20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 2010;50:1081-1083.
Kollef MH. Broad-Spectrum antimicrobials and the treatment of serious bacterial infections: Getting tt right up front. Clin Infect Dis 2008; 47: S3-13.
Lin SH, Kuo PH, Hsueh PR, Yang PC, Kuo SH.Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 2007; 12:81-87.
Goel N, Chaudhary U, Aggarwal R, Bala K. Antibiotic sensitivity pattern of Gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the Intensive care unit. Indian J Crit Care Med 2009;13: 148-151.
Gonlugur U, Bakici MZ, Akkurt I, Efeoglu T. Antibiotic susceptibility patterns among respiratory isolates of Gram-negative bacilli in a Turkish university hospital. BMC Microbiol 2004; 4: 32.
Gagneja D, Goel N, Aggarwal R, Chaudhary U. Chang- ing trend of antimicrobial resistance among Gram-neg- ative bacilli isolated from lower respiratory tract of ICU patients: A 5-year study. Indian J Crit Care Med 2011;15: 164-167.
Okesola AO, Ige OM. Trends in bacterial pathogens of lower respiratory tract infections. Ind J Chest Dis All Sc 2008; 50: 269-272.
| Files | ||
| Issue | Vol 5 No 4 (2013) | |
| Section | Articles | |
| Keywords | ||
| Acinetobacter spp. Gram-negative bacilli Klebsiella pneumoniae Lower respiratory infection Multidrug resistance | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
